about
How citation distortions create unfounded authority: analysis of a citation networkMuscle lim protein isoform negatively regulates striated muscle actin dynamics and differentiationGene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscleDistinctive patterns of microRNA expression in primary muscular disordersExpression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontinCombining gene expression data from different generations of oligonucleotide arraysInterferon-alpha/beta-mediated innate immune mechanisms in dermatomyositisAutoimmune neuromuscular disordersAn interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activityStatistical Methods in Integrative GenomicsCongenital myopathies: diseases of the actin cytoskeleton.Coexpression analysis of human genes across many microarray data setsArray lessons from the heart: focus on the genome and transcriptome of cardiomyopathies.Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy.Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell follicles.Role of Esrrg in the fibrate-mediated regulation of lipid metabolism genes in human ApoA-I transgenic miceAutoantibodies against a 43 KDa muscle protein in inclusion body myositisInclusion body myositis: laser microdissection reveals differential up-regulation of IFN-γ signaling cascade in attacked versus nonattacked myofibers.Theories of the pathogenesis of inclusion body myositis.Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles.Genomic signatures characterize leukocyte infiltration in myositis muscles.Dermatomyositis and Polymyositis.Skeletal muscle repair in a mouse model of nemaline myopathy.Genetics of inclusion-body myositis.An overview of polymyositis and dermatomyositis.Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.Type 1 interferons inhibit myotube formation independently of upregulation of interferon-stimulated gene 15.Inclusion body myositis: review of recent literature.Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscle.Gene expression profiling identifies molecular pathways associated with collagen VI deficiency and provides novel therapeutic targets.The tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapy.Recent advances in the immunogenetics of idiopathic inflammatory myopathy.Identification of specific chondroitin sulfate species in cutaneous autoimmune disease.Global gene profiling of VCP-associated inclusion body myopathy.Molecular diagnosis of inheritable neuromuscular disorders. Part II: Application of genetic testing in neuromuscular disease.Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers.Gene expression profiling in human autoimmunity.Update on idiopathic inflammatory myopathies.Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis.Advances in the immunopathophysiology of the idiopathic inflammatory myopathies: not as simple as suspected.
P2860
Q24260685-29EAE3C2-9A76-4049-82EF-F28F4A578237Q24298282-09F82B33-F492-4A73-B76C-5570195BF470Q24538577-7236621A-2C98-4E2C-B824-B6F2A595E5AFQ24675407-D9D5414A-2508-44C1-A097-39F96C07456CQ24685614-8DAD3BCA-0EB6-45EC-807A-76C85F5045BCQ24794137-468EE6EE-949D-40A6-A28C-657BCF236F61Q28246912-D674ABC6-35E6-4180-B056-FEA79DEA8425Q28261039-41A0462A-2A60-4108-8DA1-929D4DAEE421Q28303311-F6C1289F-5E1B-469F-9511-2D91931CAADDQ28385219-DFB919D9-06E3-4D05-BE70-0D01FC7F88EBQ30343979-6314EF89-4DE1-47AF-91EE-4808EF20406DQ30936126-2113AFB6-1EAC-4AED-8124-38883300D3FDQ31160132-04830C28-E154-4567-97E7-6CD98BE096D2Q33534742-D13F42AC-79C5-4CC9-8B0E-12ED764621DFQ33673190-5E14DAF4-7D1C-474A-8613-03B70E59FEA1Q33872411-11C92A39-05FE-439D-995C-05B99D01A806Q33918389-5109C260-3018-47C1-A8CA-CDE5E46183D8Q33998204-7CAA98AF-AB40-4088-B6A7-D1FDA9FE847FQ34090910-B7F737BF-0564-46E0-BB75-AF00727DFE29Q34311972-A39203BC-6184-4C0C-856D-E5D5014EC3ABQ34484782-30C5D009-5C9E-42C6-B6DE-CDA97E3FFE93Q34535933-93814F79-98AA-44DE-8F5E-BE7E8227D6B6Q34552514-FFDF4BFB-1723-4D42-B34B-31863A646A87Q34609397-DAB6B31A-DD2B-41BF-B21F-61F9053A02C3Q34667765-0AAACA44-F7F9-4B48-8D94-0B8D448A8E93Q34675925-DBB8D5EA-16B2-4562-AAC3-C02DC37E874AQ34764290-C6291D23-4B79-46C0-9ACA-8C85116E2B8FQ34903518-BED0CD58-BC89-4C07-85A8-232B1422C952Q34959366-435B47F5-116C-4B26-978C-40EE90F17B7BQ35040061-B877EE19-D219-4434-BD76-4335BF4517FAQ35450066-5BB9CB94-D377-45F5-B5A1-33206A3274FDQ35557800-CF739DBD-0272-4D8D-BAB7-FFE8BBBCA2B3Q35681780-7B43CB41-6C92-47CA-A346-D0DE15FBF3E4Q36034366-CB837ECA-CDB2-41F4-B9FC-DCDBC9807414Q36036959-D786499F-8136-4889-B6DB-1F27D346A9D3Q36342987-4E7332D9-5357-4E70-86B5-20EA4357A426Q36453363-11F5B61B-E692-46DA-A71F-898970E3731CQ36504363-5C4AF6EC-77F6-4F96-8534-70A80F23408DQ36744546-86C55E29-A1DB-4B64-BB72-46C041CDE1EDQ36905986-32D229BD-F0F7-416D-87C7-5B6A23E4B823
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Molecular profiles of inflammatory myopathies.
@en
Molecular profiles of inflammatory myopathies.
@nl
type
label
Molecular profiles of inflammatory myopathies.
@en
Molecular profiles of inflammatory myopathies.
@nl
prefLabel
Molecular profiles of inflammatory myopathies.
@en
Molecular profiles of inflammatory myopathies.
@nl
P2093
P356
P1433
P1476
Molecular profiles of inflammatory myopathies
@en
P2093
I S Kohane
J N Haslett
L M Kunkel
S A Greenberg
P304
P356
10.1212/WNL.59.8.1170
P407
P577
2002-10-01T00:00:00Z